Launch and sea-truck services resumed on 10 major river routes in Bhola on Friday (11 July) morning after a week-long suspension following the withdrawal of local cautionary signal No-3 for maritime ...

Investing.com - Goldman Sachs (NYSE: GS) has resumed coverage on CG Oncology (NASDAQ: CGON) with a Buy rating and a price target of $40.00 on Thursday. The stock, currently trading at $27.04, appears ...

Analyst Ratings Published 10/07/2025, 09:16 pm 0 Halozyme stock resumes coverage at Goldman Sachs with Neutral rating ...

Analyst Ratings Published 10-07-2025, 03:04 pm 0 Morgan Stanley resumes Verizon stock coverage with Equalweight rating VZ -1.05% ...

Investing.com - Goldman Sachs (NYSE: GS) has resumed coverage on Rhythm Pharmaceuticals (NASDAQ: RYTM) with a Buy rating and a price target of $97.00. The stock, currently trading at $89, has shown ...

Analyst Ratings Published 2025-07-10, 07:30 a/m 0 Goldman Sachs resumes Immunovant stock coverage with Neutral rating IMVT -1.81% ...

Analyst Ratings Published 2025-07-10, 07:16 a/m 0 Harmony Biosciences stock resumes coverage at Goldman Sachs with Neutral rating HRMY 3.46% ...

Analyst Ratings Published 07/10/2025, 03:12 AM 0 Goldman Sachs resumes Amylyx stock coverage with Buy rating on avexitide potential AMLX 0.00% ...